Cardiac Amyloidosis Program

The Cardiac Amyloidosis Program provides a multi-disciplinary, patient-centered care for all forms of amyloidosis that affects the heart.

We are committed to offering access to state-of-the-art approaches for both diagnosis and treatment. To accomplish this, we routinely participate in clinical trials and expanded access programs for the most promising therapies. Our patients are followed closely by nurses and pharmacists in the UCSF Advanced Heart Failure and Cardio-oncology Clinics, to help manage symptoms of heart failure and maintain the best quality of life possible.

Effective treatment of amyloidosis requires a multidisciplinary team. As part of the UCSF Comprehensive Amyloidosis Program, we work closely with other specialists from Hematology-Oncology, Neurology, Liver Transplant, Nephrology, Radiology, Pathology, and more to offer our patients the integrated treatment they need. The center serves as a resource for the support of patients, family members and caregivers. Our center is committed to promoting awareness, education, and training of physicians in the field of amyloidosis. In addition, our center promotes research endeavors through institutional, national, and international collaboration.


Mandar Aras, MD, Co-Director Cardiac Amyloidosis Program

Sandy Wong, MD, Co-Director Cardiac Amyloidosis Program

Alfred Chung, MD, Hematologist


Learn more about research and clinical trials. 

Research and Clinical Trials